Arrivent Biopharma Inc (AVBP)

Finanzdaten der Arrivent Biopharma Inc-Aktie (AVBP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	14.27%52.69	46.11	38.82	38.32	33.62
Research and Development	12.55%42.34	37.62	32.18	32.17	27.72
Operating Income/Loss	14.27%-52.69	-46.11	-38.82	-38.32	-33.62
	15.17%-49.89	-43.32	-35.54	-34.98	-31.40
Attributable To Parent	15.17%-49.89	-43.32	-35.54	-34.98	-31.40
Available To Common Stockholders, Basic	15.17%-49.89	-43.32	-35.54	-34.98	-31.40
Basic Average Shares	5.63%47.61	45.07	1.49	41.91	35.01
Diluted Average Shares	5.63%47.61	45.07	1.49	41.91	35.01
Basic Earnings Per Share	9.38%-1.05	-0.96	-0.78	-0.83	-0.90
Diluted Earnings Per Share	9.38%-1.05	-0.96	-0.78	-0.83	-0.90